pimagedine has been researched along with Toxoplasmosis, Ocular in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Toxoplasmosis, Ocular: Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S | 1 |
| Chan, CC | 1 |
| Gazzinelli, RT | 1 |
| Pham, NT | 1 |
| Cheung, MK | 1 |
| Roberge, FG | 1 |
1 other study available for pimagedine and Toxoplasmosis, Ocular
| Article | Year |
|---|---|
Protective role of nitric oxide in ocular toxoplasmosis.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Guanidines; Immunoenzyme Techniques; Mic | 1996 |